Intervention Practice of Home-based Pharmaceutical Care for Patients with Stable COPD Based on Digital Remote Management
10.3870/j.issn.1004-0781.2025.05.024
- VernacularTitle:基于数字化远程管理的稳定期慢性阻塞性肺疾病患者居家药学服务实践
- Author:
Zhipeng WANG
1
;
Huiyin XU
1
;
Bingqin WEN
1
;
Yongqi HE
1
;
Jianen ZHU
1
;
Pengjiu YU
1
;
Li WEI
1
Author Information
1. 广州医科大学附属第一医院药学部,广州 510120
- Publication Type:Journal Article
- Keywords:
Home-based pharmaceutical care;
Chronic obstructive pulmonary diseases(COPD);
Medical compliance;
Digital management
- From:
Herald of Medicine
2025;44(5):817-822
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the effect of home-based pharmaceutical care for patients with stable chronic obstruc-tive pulmonary diseases(COPD)based on a digital remote management applet.Methods A total of 237 patients with stable COPD from a hospital pharmaceutical outpatient service from March 2022 to March 2023 were divided into a control group,a home visit group,and a remote management group according to the random number table method.Patients in the home visit and re-mote management groups received home-based pharmaceutical interventions such as health science popularization,medication con-sultation,medication guidance,effect evaluation of pharmacotherapy,prescription simplification,and reorganization.Such interven-tions were not provided in the control group.Regular follow-up was performed for 12 months.Results After a pharmaceutical intervention,the operating scores of the inhalation device and medication compliance scores of the home visit and remote manage-ment groups were significantly better than the control group(P＜0.05).The improvement in medication compliance was greater in the remote management group than in the home visit group(54.3％ vs.44.6％).In the three groups between enrollment and 12 months follow-up,CAT scores decreased by 0.78,6.16,and 7.30 points in the control group,home visit group,and remote manage-ment group,respectively.The mean scores of SGRQ symptom decreased by 1.19,4.24,and 6.10 points,the mean activity scores decreased by 1.65,3.56,4.80 points,the impact mean score decreased by 1.08,4.19,5.16 points,and the mean score of the total score decreased by 1.29,4.00,4.80 points in the control group,home visit group,and remote management group,respectively.The remote management group showed dia better decline in CAT score and SGRQ score than the home visit group,and there were sig-nificant differences between the two groups compared with the control group after intervention(P＜0.05).Conclusions Digital remote management of home-based pharmaceutical care mode can effectively improve medication compliance,operation accuracy of inhalation devices,clinical symptoms,and the patient quality of life.This is an effective and efficient pharmaceutical care mode for the long-term home medication management of stable COPD patients.
